Convey Holding Parent, Inc. (CNVY) News
Filter CNVY News Items
CNVY News Results
|Loading, please wait...|
Latest CNVY News From Around the Web
Below are the latest news stories about CONVEY HEALTH SOLUTIONS HOLDINGS INC that investors may wish to consider to help them evaluate CNVY as an investment opportunity.
Even though equities have hit the pause button on the rally off of the late spring lows over the past few days, there have been some monster moves across a number of Russell 3,000 stocks.
AllScripts (MDRX) delivered earnings and revenue surprises of 12.50% and 2.27%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
1Life Healthcare, Inc. (ONEM) delivered earnings and revenue surprises of 0% and 3.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
In this article we look at why Billionaire Jeffrey Talpins Just Fled From These 10 Healthcare Stocks. Click to skip ahead and see why Billionaire Jeffrey Talpins Just Fled From These 5 Healthcare Stocks. Moderna, Inc. (NASDAQ:MRNA), Thermo Fisher Scientific Inc. (NYSE:TMO), and Danaher Corporation (NYSE:DHR) are three of the healthcare stocks that billionaire money manager […]
In a report released yesterday, Anne Samuel from J.P. Morgan maintained a Hold rating on Convey Holding Parent (CNVY – Research Report), with a price target of $10.50. The company's shares closed last Tuesday at $10.30. According to TipRanks.com, Samuel is a 4-star analyst with an average return of 16.5% and a 44.4% success rate. Samuel covers the Technology sector, focusing on stocks such as Definitive Healthcare Corp, Health Catalyst, and Signify Health. Currently, the analyst consensus on Convey Holding Parent is a Hold with an average price target of $9.83, which is a -4.6% downside from current levels.
With no specific driver pushing stocks higher, many on Wall Street expect today's bounce to fall flat.
Private equity firm TPG Inc agreed to acquire all the outstanding shares of Convey Health Solutions Holdings it does not already own, in an all-cash transaction announced on Tuesday. TPG, which currently owns about 75% of Convey Health, will pay $10.50 per share in cash for the Fort Lauderdale, Florida-based company, giving it an enterprise value of about $1.1 billion, a statement said. Convey Health's stock, which had closed at $4.32 per share on Friday, more than doubled following the announcement of TPG's take-private deal.
TPG Capital, private equity, has agreed to acquire Convey Health Solutions Holdings Inc (NYSE: CNVY) for $10.50 per share in cash, representing an enterprise value of approximately $1.1 billion. The purchase price represents approximately 99% over Convey's 30-day volume-weighted average price per share as of June 17 and a premium of approximately 143% to the last closing price. Convey is a specialized healthcare technology and services company that provides healthcare-specific, compliant member
Convey Health Solutions Holdings, Inc. (NYSE: CNVY) ("Convey"), a leading healthcare technology and services company, announced today that it has entered into a definitive merger agreement pursuant to which TPG Capital, the private equity platform of global alternative asset management firm TPG ("TPG") and Convey's principal shareholder, will acquire all of the outstanding shares of Convey common stock not currently owned by TPG or certain management and director shareholders for $10.50 per shar
Loss-making Convey Health Solutions Holdings (NYSE:CNVY) sheds a further US$42m, taking total shareholder losses to 67% over 1 year
The nature of investing is that you win some, and you lose some. Anyone who held Convey Health Solutions Holdings, Inc...